Cancer Genetics

Edited by: Eugene Russo Photo: Robert Neroni Photo: Michael Price PERFECT FHIT: Kay Huebner and Carlo Croce of the Kimmel Cancer Center discovered a correlation between the deletion of the FHIT gene and the onset of lung cancer. G. Sozzi, M. L. Veronese, M. Negrini, R. Baffa, M.G. Cotticelli, H. Inoue, S. Tornielli, S. Pilotti, L. De Gregorio, U. Pastorino, M. A. Pierotti, M. Ohta, K. Huebner, C. Croce, "The FHIT gene at 3p14.2 is abnormal in lung cancer," Cell, 85:17-26, 1996. (Cited in mor

Written byEugene Russo
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Edited by: Eugene Russo

Photo: Robert NeroniPhoto: Michael Price
PERFECT FHIT: Kay Huebner and Carlo Croce of the Kimmel Cancer Center discovered a correlation between the deletion of the FHIT gene and the onset of lung cancer.
G. Sozzi, M. L. Veronese, M. Negrini, R. Baffa, M.G. Cotticelli, H. Inoue, S. Tornielli, S. Pilotti, L. De Gregorio, U. Pastorino, M. A. Pierotti, M. Ohta, K. Huebner, C. Croce, "The FHIT gene at 3p14.2 is abnormal in lung cancer," Cell, 85:17-26, 1996. (Cited in more than 85 publications as of February 1998) Comments by Carlo Croce, Kimmel Cancer Center, Jefferson Medical College, Philadelphia

Mortality rates for lung cancer victims have not improved significantly in the last 20 years. Recently, scientists have looked to the molecular pathogenesis of the disease in an attempt to improve diagnosis and treatment. The most popular subjects of investigation have been the tumor suppressor gene p53, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies